» Articles » PMID: 38651133

An Unwanted but Long-Known Company: Post-Viral Symptoms in the Context of Past Pandemics in Switzerland (and Beyond)

Overview
Specialty Public Health
Date 2024 Apr 23
PMID 38651133
Authors
Affiliations
Soon will be listed here.
Abstract

Some people do not fully recover from an acute viral infection and experience persistent symptoms or incomplete recovery for months or even years. This is not unique to the SARS-CoV-2 virus and history shows that post-viral conditions like post COVID-19 condition, also referred to as Long Covid, are not new. In particular, during and after pandemics caused by respiratory viruses in which large parts of the population were infected or exposed, professional and public attention was increased, not least because of the large number of people affected. Given the current relevance of the topic, this article aims to narratively review and summarize the literature on post-viral symptoms during past pandemics and to supplement and illustrate it with Swiss examples from the pandemics of 1890, 1918-1920 and later. Post-viral diseases were an increasingly emphasised health topic during and after past pandemics triggered by respiratory infections over the last 150 years. In the next pandemic, it should not be surprising that post-viral conditions will again play a role, and pandemic plans should reflect this.

Citing Articles

Profiling the persistent and episodic nature of long COVID symptoms and the impact on quality of life and functional status: a cohort observation study.

Owen R, Ashton R, Bewick T, Copeland R, Ferraro F, Kennerley C J Glob Health. 2025; 15:04006.

PMID: 39913532 PMC: 11801655. DOI: 10.7189/jogh.15.04006.


The health and demographic impacts of the "Russian flu" pandemic in Switzerland in 1889/1890 and in the years thereafter.

Suter J, Devos I, Matthes K, Staub K Epidemiol Infect. 2024; 152:e174.

PMID: 39557608 PMC: 11696589. DOI: 10.1017/S0950268824001651.

References
1.
Jang H, Boltz D, Webster R, Smeyne R . Viral parkinsonism. Biochim Biophys Acta. 2008; 1792(7):714-21. PMC: 4642437. DOI: 10.1016/j.bbadis.2008.08.001. View

2.
West E, Anker D, Amati R, Richard A, Wisniak A, Butty A . Corona Immunitas: study protocol of a nationwide program of SARS-CoV-2 seroprevalence and seroepidemiologic studies in Switzerland. Int J Public Health. 2020; 65(9):1529-1548. PMC: 7584867. DOI: 10.1007/s00038-020-01494-0. View

3.
Briggs A, Vassall A . Count the cost of disability caused by COVID-19. Nature. 2021; 593(7860):502-505. DOI: 10.1038/d41586-021-01392-2. View

4.
Dimka J, Schneider B, Mamelund S . Protocol for a systematic review to understand the long-term mental-health effects of influenza pandemics in the pre-COVID-19 era. Scand J Public Health. 2023; 52(3):391-396. PMC: 11067412. DOI: 10.1177/14034948231217362. View

5.
Willi S, Luthold R, Hunt A, Hanggi N, Sejdiu D, Scaff C . COVID-19 sequelae in adults aged less than 50 years: A systematic review. Travel Med Infect Dis. 2021; 40:101995. PMC: 7898978. DOI: 10.1016/j.tmaid.2021.101995. View